The previous week proved to be quite eventful for Mylan NV (NASDAQ:MYL). Reports claim that the company had taken the court’s way to protect one of its respiratory medicines that faced a stiff competition from another pharmaceutical company. What’s In For The Company: The U.S. Court of Appeals took company’s side and supported four patents […]
